Accès ouvert · CC BY

Bacillus Coagulans as potent intervention for irritable bowel syndrome: A systematic review and meta-analysis of randomized control trials

Article scientifique 2023 Sciences de la santé Anglais

Résumé

Abstract Introduction: Irritable bowel syndrome (IBS) is the most common functional GIT disorder. Bacillus coagulans (BC) is a potent spore-forming probiotic that has been proposed as a potent supplement that can improve GIT dysbiosis and relieve IBS symptoms. We aim to assess the effect of BC on different IBS symptoms. Methods: We searched seven databases for RCTs that compare the use of BC versus placebo in the management of IBS symptoms. Results: Our search finally retrieved seven RCTs after extensive screening. Our analysis revealed that BC significantly improved the severity of IBS symptoms such as urgency {MD: -1.05, 95% CI: -1.33; -0.77}, bowel habit satisfaction {MD: -1.40, 95% CI: -1.68; -1.13}, straining {MD: -1. 22, 95% CI: -1.61; -0.82}, the passage of gas {MD: -1.25, 95% CI: -1.51; -0.99}, incomplete evacuation {MD: -1.06, 95% CI: -1.55; -0.57}, and the total score of symptom severity {MD: -10.13, 95% CI: -11.61; -8.66, (P < 0.00001)}. We also found a significant improvement in the physician’s global assessment score at 8 weeks {MD: 1.61, 95% CI: 0.61; 2.60, (P = 0.002)}; however, results were not significant at 4 weeks (P = 0.48). Moreover, our results indicate a significant decrease in the discomfort score after 4 and 8 weeks, the bloating score after 2, 4, 8, and 11 weeks and the vomiting score. Regarding abdominal pain, BC significantly lowered pain score after 2, 4, 8, and (11-13) weeks. Conclusion: BC is a very effective probiotic in reducing the severity of IBS symptoms and abdominal pain with no serious adverse events. Future studies are needed to assess the use of BC as a long-term regimen and compare different subspecies of BC.

Citer ce document

AbdelQadir, Y. H., Nabhan, A. I., Althawadi, Y. J., Belal, M. M., Feiter, Y. Y., Madian, M. S., Omran, H. A. M., AbdelAzim, A. A., Abdelghafar, Y. A., & Nashwan, A. J. (2023). Bacillus Coagulans as potent intervention for irritable bowel syndrome: A systematic review and meta-analysis of randomized control trials. Research Square. https://doi.org/10.21203/rs.3.rs-2800016/v1

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 26/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 12

Téléchargements (hors robots) : 0

Méthode de comptage